OBIO

6.5806.00%
WR

William Reed Little

Executive Vice President of Corporate Development & Strategy

Mr. William Reed Little, also known as Bill, is Director of Medyria AG. He is Executive Vice President of Corporate Development and Strategy of Orchestra BioMed Holdings, Inc. from June 2023. He had been Chief Operating Officer at Neovasc Inc. from November 07, 2019 to April 2023. He serves as the Director at SpectraWAVE, Inc. since 2022. Mr. Little joins Neovasc after serving as Abbott’s Global Head of Customer and New Market Insights and Divisional Vice President of Global Marketing. Prior to Abbott, Mr. Little was Vice President, Global Marketing at C.R. Bard, now part of Becton Dickson, where he executed on a marketing strategy for the companies. He served as Vice President of Global Cardiovascular Therapies for St. Jude Medical, where he oversaw marketing and strategy for the structural heart and vascular portfolios; Vice President, Global Marketing at Bard Peripheral Vascular; and in a variety of cardiovascular sales and marketing roles at Boston Scientific. He also spent years at Boston Scientific in a variety of domestic and international commercial roles. Mr. Little holds a Bachelor of Science in business administration and marketing from the University of Colorado.

Positions